Innovative Medicines Canada
Innovative Medicines Canada has met with MPs 66 times since January 2024, reaching 44 MPs across 4 parties. Most recent contact: July 22, 2026.
What they're asking for
In the registry's own words. Descriptions are only filed for meetings since mid-2024.
Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes
July 22, 2026 · Gord Johns · NDP · Health; Intellectual Property; Science and Technology; Research and Development; Economic Development
Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations
July 13, 2026 · Karim Bardeesy · Liberal · Health; Intellectual Property; International Relations; International Trade; Science and Technology
Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB)
May 26, 2026 · Ali Ehsassi · Liberal · Health; Intellectual Property; International Relations; International Trade; Science and Technology
Free trade agreements as they relate to the biopharmaceutical industry
December 9, 2025 · Jagsharan Singh Mahal · Conservative · Health; Intellectual Property; International Relations; International Trade; Science and Technology
Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals
February 6, 2025 · Randy Hoback · Conservative · Health; Intellectual Property; International Relations; International Trade; Agriculture
Proposed pharmacare legislation related to any future national pharmacare program
October 16, 2024 · Luc Thériault · Bloc Québécois · Health; Intellectual Property; International Trade; Science and Technology; Taxation and Finance
Full meeting log
66 MP-directed communications since January 2024, from the Registry of Lobbyists.
| Date | MP |
|---|---|
| 2026-07-22 | Gord Johns · NDP |
| 2026-07-13 | Karim Bardeesy · Liberal |
| 2026-07-08 | Raquel Dancho · Conservative |
| 2026-06-17 | Marjorie Michel · Liberal |
| 2026-06-02 | Tom Kmiec · Conservative |
| 2026-06-02 | Dan Mazier · Conservative |
| 2026-06-02 | Sonia Sidhu · Liberal |
| 2026-05-26 | Ali Ehsassi · Liberal |
| 2026-04-15 | Maggie Chi · Liberal |
| 2026-04-02 | Marjorie Michel · Liberal |
| 2026-03-27 | John Zerucelli · Liberal |
| 2026-03-25 | Helena Jaczek · Liberal |
| 2026-03-11 | Tom Kmiec · Conservative |
| 2026-03-09 | Maggie Chi · Liberal |
| 2026-02-23 | Karim Bardeesy · Liberal |
| 2026-02-23 | Dominic LeBlanc · Liberal |
| 2026-02-23 | Marjorie Michel · Liberal |
| 2026-02-09 | Maggie Chi · Liberal |
| 2025-12-09 | Jagsharan Singh Mahal · Conservative |
| 2025-12-02 | Karim Bardeesy · Liberal |
| 2025-12-02 | Mélanie Joly · Liberal |
| 2025-10-22 | Matt Jeneroux · Liberal |
| 2025-10-21 | Burton Bailey · Conservative |
| 2025-10-21 | Parm Bains · Liberal |
| 2025-10-21 | Chris Bittle · Liberal |
Show all 66 meetings
| Date | MP |
|---|---|
| 2025-10-21 | Maxime Blanchette-Joncas · Bloc Québécois |
| 2025-10-21 | Maggie Chi · Liberal |
| 2025-10-21 | Peter Fragiskatos · Liberal |
| 2025-10-21 | Karina Gould · Liberal |
| 2025-10-21 | Brendan Hanley · Liberal |
| 2025-10-21 | Kurt Holman · Conservative |
| 2025-10-21 | Helena Jaczek · Liberal |
| 2025-10-21 | Tom Kmiec · Conservative |
| 2025-10-21 | Scott Reid · Conservative |
| 2025-10-21 | Anna Roberts · Conservative |
| 2025-10-21 | Francis Scarpaleggia · Liberal |
| 2025-10-21 | Charles Sousa · Liberal |
| 2025-10-21 | Matt Strauss · Conservative |
| 2025-10-21 | Corey Tochor · Conservative |
| 2025-07-18 | Mélanie Joly · Liberal |
| 2025-02-06 | Randy Hoback · Conservative |
| 2025-01-21 | Gabriel Ste-Marie · Bloc Québécois |
| 2025-01-21 | Luc Thériault · Bloc Québécois |
| 2024-10-16 | Luc Thériault · Bloc Québécois |
| 2024-09-24 | Jean-Denis Garon · Bloc Québécois |
| 2024-09-24 | Bernard Généreux · Conservative |
| 2024-09-24 | Tom Kmiec · Conservative |
| 2024-09-24 | Tom Kmiec · Conservative |
| 2024-09-24 | Shuvaloy Majumdar · Conservative |
| 2024-09-24 | Corey Tochor · Conservative |
| 2024-09-23 | Yvan Baker · Liberal |
| 2024-09-23 | Tony Baldinelli · Conservative |
| 2024-09-23 | Sean Casey · Liberal |
| 2024-09-23 | Adam Chambers · Conservative |
| 2024-09-23 | Julie Dzerowicz · Liberal |
| 2024-09-23 | Peter Fragiskatos · Liberal |
| 2024-09-23 | Helena Jaczek · Liberal |
| 2024-09-23 | Matt Jeneroux · Liberal |
| 2024-09-23 | Yasir Naqvi · Liberal |
| 2024-09-23 | Francis Scarpaleggia · Liberal |
| 2024-09-23 | Ryan Turnbull · Liberal |
| 2024-09-23 | Rechie Valdez · Liberal |
| 2024-06-07 | Randy Hoback · Conservative |
| 2024-05-23 | Blaine Calkins · Conservative |
| 2024-05-23 | Tom Kmiec · Conservative |
| 2024-05-07 | Yasir Naqvi · Liberal |
At committee
Innovative Medicines Canada has testified at 4 House committee meetings this Parliament, as listed by the House. Lobbying is one channel; this is the public one.
- Mr. Michael Dietrich, Vice President
- Dr. Bettina Hamelin, President and Chief Executive Officer
- Ms. Jennifer Buckley, Senior Director
- Dr. Bettina Hamelin, President and Chief Executive Officer
- Ms. Jennifer Buckley, Senior Director
- Dr. Bettina Hamelin, President and Chief Executive Officer